New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

FDA Approves First Alopecia Treatment for Children

Litfulo will be available for consumers in the coming weeks, with a list price of $49k for a year's supply.

Towfiqu Barbhuiya
Towfiqu Barbhuiya

A recent ABC News article noted that the FDA has granted approval for the first-ever alopecia treatment for children. The medication, called ritlecitinib and marketed as Litfulo by Pfizer, is a once-daily pill designed for children aged 12 and older with severe alopecia areata, a condition characterized by hair loss due to the body attacking its own hair follicles. Though the treatment costs nearly $50k/year, Pfizer says the actual cost to patients will vary based on individual healthcare plans, and the company plans to offer copay savings and a patient assistance program.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts